Advances in the comprehensive treatment of pancreatic cancer
10.3760/cma.j.cn115396-20210613-00223
- VernacularTitle:胰腺癌的综合治疗进展
- Author:
Yong GUO
1
;
Jianping GONG
;
Peizhi LI
Author Information
1. 重庆市长寿区人民医院肝胆外科 401220
- Keywords:
Pancreatic neoplasms;
Therapeutics;
Advances
- From:
International Journal of Surgery
2021;48(9):638-643
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is one of the most malignant digestive cancer with high morbidity and mortality. Surgical treatment is considered the only way to cure pancreatic cancer. For resectable pancreatic cancer, the principles of "artery-frst approach" and "systematic mesopancreas dissection" have improved the increase the local radicality and reduce the local recurrence rate. For borderline resectable pancreatic cancer and locally advanced pancreatic cancer, neoadjuvant chemotherapy can be used before surgical resection. Although there are no targeted and immunotherapeutic drugs for pancreatic cancer, clinical studies on monoclonal antibodies are ongoing. Chimeric antigen receptor T cell therapy and irreversible electroporation are emerging therapies in the treatment of pancreatic cancer. In the present study, the status and progress of comprehensive treatment for pancreatic cancer are reviewed.
